Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| NATIONAL HEALTH INVESTORS INCNHI · Entity 4125 | Director | January 27, 2026 | January 29, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
NATIONAL HEALTH INVESTORS INC
Report date January 27, 2026 · Filed January 29, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectTrustee | 205,548 |
Reported balance
After 2026-01-27 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2026-01-27 · Exercise / conversion · Acquired 25,000 · Balance 205,548 |
| Common StockSEC Table I · non-derivative | IndirectTrustee | 215,548 |
Reported balance
After 2026-01-27 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2026-01-27 · Exercise / conversion · Acquired 10,000 · Balance 215,548 |
| Common StockSEC Table I · non-derivative | IndirectTrustee | 184,455 |
Reported balance
After 2026-01-27 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2026-01-27 · Tax withholding · Disposed 31,093 · Balance 184,455 |
| Stock Options (Right to Buy) 2-25-2021SEC Table II · derivative / convertible security · Conversion / exercise price $69.20 · Expires 2026-02-25 | Direct | 0 |
Reported balance
After 2026-01-27 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-01-27 · Exercise / conversion · Disposed 25,000 · Balance 0 |
| Stock Option (Right to Buy) 2025SEC Table II · derivative / convertible security · Conversion / exercise price $73.34 · Expires 2030-03-03 | Direct | 0 |
Reported balance
After 2026-01-27 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-01-27 · Exercise / conversion · Disposed 10,000 · Balance 0 |
| Common StockSEC Table I · non-derivative | IndirectTrustee - CLAT | 40,000 |
Reported balance
Holding disclosure · report date 2026-01-27 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 40,000 |
| Common StockSEC Table I · non-derivative | IndirectFamily Partnership | 342,096 |
Reported balance
Holding disclosure · report date 2026-01-27 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 342,096 |
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
NATIONAL HEALTHCARE CORP
Report date June 08, 2026 · Filed June 10, 2026
Section 16 reporting ended · disclosed 2017-02-10. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Shares of Common Stock - Trust ISEC Table I · non-derivative | IndirectTrustee | 17,579 |
Reported balance
After 2026-06-08 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2026-06-08 · Exercise / conversion · Acquired 4,000 · Balance 17,579 F1: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 5, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). |
| Shares of Common Stock - Trust ISEC Table I · non-derivative | IndirectTrustee | 13,579 |
Reported balance
After 2026-06-08 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2026-06-08 · Gift · Disposed 4,000 · Balance 13,579 F2: Total amount of shares beneficially owned following transactions reported on this form. |
| Option to Purchase Common Stock [2022 Grant]SEC Table II · derivative / convertible security · Conversion / exercise price $69.19 · Expires 2027-05-04 | Direct | 3,500 |
Reported balance
After 2026-06-08 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-06-08 · Exercise / conversion · Disposed 4,000 · Balance 3,500 F1: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 5, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). |
| Shares of Common Stock - PartnershipSEC Table I · non-derivative | IndirectGeneral Partner | 430,341 |
Reported balance
Holding disclosure · report date 2026-06-08 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 430,341 |
| Option to Purchase Common Stock [2023 Grant]SEC Table II · derivative / convertible security · Conversion / exercise price $55.75 · Expires 2028-05-03 | Direct | 7,500 |
Reported balance
Holding disclosure · report date 2026-06-08 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 7,500 |
| Option to Purchase Common Stock [2024 Grant]SEC Table II · derivative / convertible security · Conversion / exercise price $96.03 · Expires 2029-05-08 | Direct | 7,500 |
Reported balance
Holding disclosure · report date 2026-06-08 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 7,500 |
| Option to Purchase Common Stock [2025 Grant]SEC Table II · derivative / convertible security · Conversion / exercise price $94.66 · Expires 2030-05-07 | Direct | 7,500 |
Reported balance
Holding disclosure · report date 2026-06-08 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 7,500 |
| Option to Purchase Common Stock [2026 Grant]SEC Table II · derivative / convertible security · Conversion / exercise price $171.42 · Expires 2031-05-06 | Direct | 7,500 |
Reported balance
Holding disclosure · report date 2026-06-08 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 7,500 |
Filing footnotes · ownership attribution and instrument terms
F1: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 5, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).
F2: Total amount of shares beneficially owned following transactions reported on this form.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 07, 2020 Filed May 8, 2020 20:13 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to Purchase Common Stock · Derivative | 7,500 | $0.00 Strike: $64.64 | $0.00 |
DisclosureSEC source: 0001437749-20-010060 · rdgdoc.xml · derivative · entry 5 ADAMS ROBERT G · CIK 0001012855 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2025-05-06 F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 7, 2020. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| February 25, 2020 Filed Feb 26, 2020 18:05 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 3,460 | $0.00 Strike: $61.90 | $0.00 |
DisclosureSEC source: 0001437749-20-003567 · rdgdoc.xml · derivative · entry 4 ADAMS ROBERT G · CIK 0001012855 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,460 shares Expires 2023-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 25, 2020 Filed Feb 26, 2020 18:05 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionShares of Common Stock - Partnership | 3,460 | $61.90 | $214,174.00 |
DisclosureSEC source: 0001437749-20-003567 · rdgdoc.xml · nonDerivative · entry 1 ADAMS ROBERT G · CIK 0001012855 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · General Partner Disclosed balance after: 425,657 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 3, 2018. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| May 09, 2019 Filed May 10, 2019 20:44 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to Purchase Common Stock · Derivative | 7,500 | $0.00 Strike: $77.92 | $0.00 |
DisclosureSEC source: 0001437749-19-009502 · rdgdoc.xml · derivative · entry 5 ADAMS ROBERT G · CIK 0001012855 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2024-05-08 F1 · shares: These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 9, 2019. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| March 19, 2019 Filed Mar 20, 2019 19:41 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 2,020 | $0.00 Strike: $61.90 | $0.00 |
DisclosureSEC source: 0001437749-19-005347 · rdgdoc.xml · derivative · entry 4 ADAMS ROBERT G · CIK 0001012855 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,460 Underlying: Common Stock · 5,480 shares Expires 2023-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option was amended November 8, 2018. Read SEC document |
| March 19, 2019 Filed Mar 20, 2019 19:41 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionShares of Common Stock - Partnership | 2,020 | $61.90 | $125,038.00 |
DisclosureSEC source: 0001437749-19-005347 · rdgdoc.xml · nonDerivative · entry 1 ADAMS ROBERT G · CIK 0001012855 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · General Partner Disclosed balance after: 422,197 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 3, 2018. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| November 08, 2018 Filed Nov 13, 2018 22:03 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to purchase common stock · Derivative | 5,480 | Not disclosed Strike: $61.90 | Not disclosed |
DisclosureSEC source: 0001437749-18-020612 · rdgdoc.xml · derivative · entry 6 ADAMS ROBERT G · CIK 0001012855 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,480 Underlying: Common Stock · 5,480 shares Expires 2023-05-02 F1 · kind: The reported transactions involve an amendment to two outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · price: The reported transactions involve an amendment to two outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · derivative.exercise_date: The reported transactions involve an amendment to two outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| November 08, 2018 Filed Nov 13, 2018 22:03 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Disposition to issuerOption to purchase common stock · Derivative | 5,480 | Not disclosed Strike: $61.90 | Not disclosed |
DisclosureSEC source: 0001437749-18-020612 · rdgdoc.xml · derivative · entry 5 ADAMS ROBERT G · CIK 0001012855 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,480 shares Expires 2023-05-02 F1 · kind: The reported transactions involve an amendment to two outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · price: The reported transactions involve an amendment to two outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · derivative.exercise_date: The reported transactions involve an amendment to two outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| November 08, 2018 Filed Nov 13, 2018 22:03 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to purchase common stock · Derivative | 5,775 | Not disclosed Strike: $72.94 | Not disclosed |
DisclosureSEC source: 0001437749-18-020612 · rdgdoc.xml · derivative · entry 4 ADAMS ROBERT G · CIK 0001012855 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,775 Underlying: Common Stock · 5,775 shares Expires 2022-05-08 F1 · kind: The reported transactions involve an amendment to two outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · price: The reported transactions involve an amendment to two outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · derivative.exercise_date: The reported transactions involve an amendment to two outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| November 08, 2018 Filed Nov 13, 2018 22:03 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Disposition to issuerOption to purchase common stock · Derivative | 5,775 | Not disclosed Strike: $72.94 | Not disclosed |
DisclosureSEC source: 0001437749-18-020612 · rdgdoc.xml · derivative · entry 3 ADAMS ROBERT G · CIK 0001012855 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,775 shares Expires 2022-05-08 F1 · kind: The reported transactions involve an amendment to two outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · price: The reported transactions involve an amendment to two outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · derivative.exercise_date: The reported transactions involve an amendment to two outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| May 03, 2018 Filed May 4, 2018 19:31 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 2,020 | $0.00 Strike: $61.90 | $0.00 |
DisclosureSEC source: 0001437749-18-008679 · rdgdoc.xml · derivative · entry 4 ADAMS ROBERT G · CIK 0001012855 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,480 Underlying: Common Stock · 7,500 shares Expires 2023-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 03, 2018 Filed May 4, 2018 19:31 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionShares of Common Stock - Partnership | 2,020 | $61.90 | $125,038.00 |
DisclosureSEC source: 0001437749-18-008679 · rdgdoc.xml · nonDerivative · entry 1 ADAMS ROBERT G · CIK 0001012855 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · General Partner Disclosed balance after: 420,177 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 3, 2018. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| May 03, 2018 Filed May 4, 2018 15:40 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to Purchase Common Stock · Derivative | 7,500 | $0.00 Strike: $61.90 | $0.00 |
DisclosureSEC source: 0001437749-18-008628 · rdgdoc.xml · derivative · entry 4 ADAMS ROBERT G · CIK 0001012855 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2023-05-02 F1 · shares: These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 3, 2018. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| September 12, 2017 Filed Sep 13, 2017 19:16 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 1,725 | $0.00 Strike: $72.94 | $0.00 |
DisclosureSEC source: 0001437749-17-015902 · rdgdoc.xml · derivative · entry 3 ADAMS ROBERT G · CIK 0001012855 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,775 Underlying: Common Stock · 7,500 shares Expires 2018-05-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 12, 2017 Filed Sep 13, 2017 19:16 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionShares of Common Stock - Partnership | 1,725 | $72.94 | $125,821.50 |
DisclosureSEC source: 0001437749-17-015902 · rdgdoc.xml · nonDerivative · entry 1 ADAMS ROBERT G · CIK 0001012855 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · General Partner Disclosed balance after: 418,157 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 9, 2017. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| May 09, 2017 Filed May 10, 2017 17:58 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to Purchase Common Stock · Derivative | 7,500 | $0.00 Strike: $72.94 | $0.00 |
DisclosureSEC source: 0001047335-17-000100 · edgar.xml · derivative · entry 4 ADAMS ROBERT G · CIK 0001012855 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2018-05-08 F1 · shares: These stock options were granted pursuant to the Company's 2010 Omnibus Equity Incentive Plan on May 9, 2017. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.